Tenax Therapeutics Stock Probability of Future Stock Price Finishing Over 5.06
| TENX Stock | USD 5.06 0.14 2.85% |
Tenax |
Tenax Therapeutics Target Price Odds to finish over 5.06
The tendency of Tenax Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 5.06 | 90 days | 5.06 | under 4 |
Based on a normal probability distribution, the odds of Tenax Therapeutics to move above the current price in 90 days from now is under 4 (This Tenax Therapeutics probability density function shows the probability of Tenax Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.04 . This usually implies Tenax Therapeutics market returns are sensitive to returns on the market. As the market goes up or down, Tenax Therapeutics is expected to follow. Additionally Tenax Therapeutics has an alpha of 0.1974, implying that it can generate a 0.2 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Tenax Therapeutics Price Density |
| Price |
Predictive Modules for Tenax Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Tenax Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Tenax Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Tenax Therapeutics is not an exception. The market had few large corrections towards the Tenax Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Tenax Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Tenax Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.20 | |
β | Beta against Dow Jones | 1.04 | |
σ | Overall volatility | 0.56 | |
Ir | Information ratio | 0.06 |
Tenax Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Tenax Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Tenax Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Tenax Therapeutics had very high historical volatility over the last 90 days | |
| Tenax Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (7.71 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Tenax Therapeutics currently holds about 7.23 M in cash with (5.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.29. | |
| Tenax Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Latest headline from globenewswire.com: Tenax Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update |
Tenax Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Tenax Stock often depends not only on the future outlook of the current and potential Tenax Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Tenax Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 248.4 K | |
| Cash And Short Term Investments | 9.8 M |
Tenax Therapeutics Technical Analysis
Tenax Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Tenax Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Tenax Therapeutics. In general, you should focus on analyzing Tenax Stock price patterns and their correlations with different microeconomic environments and drivers.
Tenax Therapeutics Predictive Forecast Models
Tenax Therapeutics' time-series forecasting models is one of many Tenax Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Tenax Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Tenax Therapeutics
Checking the ongoing alerts about Tenax Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Tenax Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Tenax Therapeutics had very high historical volatility over the last 90 days | |
| Tenax Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (7.71 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Tenax Therapeutics currently holds about 7.23 M in cash with (5.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.29. | |
| Tenax Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Latest headline from globenewswire.com: Tenax Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update |
Additional Tools for Tenax Stock Analysis
When running Tenax Therapeutics' price analysis, check to measure Tenax Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenax Therapeutics is operating at the current time. Most of Tenax Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenax Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenax Therapeutics' price. Additionally, you may evaluate how the addition of Tenax Therapeutics to your portfolios can decrease your overall portfolio volatility.